Alessandro Rambaldi to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Alessandro Rambaldi has written about Antineoplastic Agents, Immunological.
Connection Strength
0.258
-
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19. Leukemia. 2021 09; 35(9):2710-2714.
Score: 0.132
-
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen. Biol Blood Marrow Transplant. 2017 Jul; 23(7):1102-1109.
Score: 0.099
-
Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors. Cytotherapy. 2018 08; 20(8):1077-1088.
Score: 0.027